bromochloroacetic-acid has been researched along with naphthalene* in 4 studies
4 other study(ies) available for bromochloroacetic-acid and naphthalene
Article | Year |
---|---|
The utility of naphthyl-keratin adducts as biomarkers for jet-fuel exposure.
We investigated the association between biomarkers of dermal exposure, naphthyl-keratin adducts (NKA), and urine naphthalene biomarker levels in 105 workers routinely exposed to jet-fuel. A moderate correlation was observed between NKA and urine naphthalene levels (pā=ā0.061). The NKA, post-exposure breath naphthalene, and male gender were associated with an increase, while CYP2E1*6 DD and GSTT1-plus (++/+-) genotypes were associated with a decrease in urine naphthalene level (pā<ā0.0001). The NKA show great promise as biomarkers for dermal exposure to naphthalene. Further studies are warranted to characterize the relationship between NKA, other exposure biomarkers, and/or biomarkers of biological effects due to naphthalene and/or PAH exposure. Topics: Adolescent; Adult; Air Pollutants, Occupational; Aircraft; Biomarkers; Cytochrome P-450 CYP2E1; Enzyme-Linked Immunosorbent Assay; Female; Gas Chromatography-Mass Spectrometry; Genotype; Glutathione Transferase; Humans; Hydrocarbons; Keratins; Male; Military Personnel; Naphthalenes; Occupational Exposure; Polycyclic Aromatic Hydrocarbons; Regression Analysis; Skin; Teratogens; Young Adult | 2011 |
S-arylcysteine-keratin adducts as biomarkers of human dermal exposure to aromatic hydrocarbons.
To measure biomarkers of skin exposure to ubiquitous industrial and environmental aromatic hydrocarbons, we sought to develop an ELISA to quantitate protein adducts of metabolites of benzene and naphthalene in the skin of exposed individuals. We hypothesized that electrophilic arene oxides formed by CYP isoforms expressed in the human skin react with nucleophilic sites on keratin, the most abundant protein in the stratum corneum that is synthesized de novo during keratinocyte maturation and differentiation. The sulfhydryl groups of cysteines in the head region of the keratin proteins 1 (K1) and 10 (K10) are likely targets. The following synthetic S-arylcysteines were incorporated into 10-mer head sequences of K1 [GGGRFSS( S-aryl-C)GG] and K10 [GGGG( S-aryl-C)GGGGG] to form the predicted immunogenic epitopes for antibody production for ELISA: S-phenylcysteine-K1 (SPK1), S-phenylcysteine-K10 (SPK10), S-(1-naphthyl)cysteine-K1 (1NK1), S-(1-naphthyl)cysteine-K10 (1NK10), S-(2-naphthyl)cysteine-K1 (2NK1), and S-(2-naphthyl)cysteine-K10 (2NK10). Analysis by ELISA was chosen based on its high throughput and sensitivity, and low cost. The synthetic modified oligopeptides, available in quantity, served both as immunogens and as chemical standards for quantitative ELISA. Polyclonal rabbit antibodies produced against the naphthyl-modified keratins reacted with their respective antigens with threshold sensitivities of 15-31 ng/mL and high specificity over a linear range up to 500 ng/mL. Anti- S-phenylcysteine antibodies were not sufficiently specific or sensitive toward the target antigens for use in ELISA under our experimental conditions. In dermal tape-strip samples collected from 13 individuals exposed to naphthalene-containing jet fuel, naphthyl-conjugated peptides were detected at levels from 0.343 +/- 0.274 to 2.34 +/- 1.61 pmol adduct/microg keratin but were undetectable in unexposed volunteers. This is the first report of adducts of naphthalene (or of any polycyclic aromatic hydrocarbon) detected in the exposed intact human skin. Quantitation of naphthyl-keratin adducts in the skin of exposed individuals will allow us to investigate the importance of dermal penetration, metabolism, and adduction to keratin and to predict more accurately the contribution of dermal exposure to systemic dose for use in exposure and risk-assessment models. Topics: Adult; Aircraft; Benzene; Biomarkers; Cysteine; Enzyme-Linked Immunosorbent Assay; Female; Humans; Keratins; Male; Naphthalenes; Occupational Exposure; Skin | 2008 |
Determination of keratin protein in a tape-stripped skin sample from jet fuel exposed skin.
Chemical contaminants or their metabolites may bind to and react with keratin proteins in the stratum corneum of the skin. Here, we present a tape-stripping method for the removal and quantification of keratin from the stratum corneum for normalization of extracted concentrations of naphthalene (as a marker for jet fuel exposure) from 12 human volunteers before and after exposure to jet fuel (JP-8). Due to the potential for removal of variable amounts of squamous tissue from each tape-strip sample, keratin was extracted and quantified using a modified Bradford method. Confirmation of the extraction of keratin was verified by western blotting using a monoclonal mouse anti-human cytokeratin antibody. Naphthalene was quantified in the sequential tape strips collected from the skin between 10 and 25 min after a single dose of JP-8 was initially applied. The penetration of jet fuel into the stratum corneum was demonstrated by the fact that the average mass of naphthalene recovered by a tape strip decreased with increased exposure time and subsequent tape strips and that the evaporation of naphthalene was observed to be negligible. There were no significant differences in the amount of keratin or naphthalene removed by tape strips between males and females, between age groups, races or degrees of skin pigmentation. We conclude that (i) the amount of keratin removed with tape strips was not affected by up to a 25 min exposure to JP-8 and (ii) there was a substantial decrease in the amount of keratin removed with consecutive tape strips from the same site, thus, adjusting the amount of naphthalene by the amount of keratin measured in a tape-strip sample should improve the interpretation of the amount of this analyte using this sampling approach. Although we found that normalization of the naphthalene to the amount of keratin in the tape-strip samples did not affect the ability of this method to quantify the dermal exposure to JP-8 under these laboratory conditions, the actual concentration of naphthalene (as a marker for JP-8 exposure) per unit of keratin in a tape-strip sample can be determined using this method and may prove to be required when measuring occupational exposures under field conditions. Topics: Adhesives; Adult; Aircraft; Blotting, Western; Epidermis; Female; Fuel Oils; Humans; Keratins; Male; Middle Aged; Naphthalenes; Occupational Exposure; Skin; Skin Absorption | 2004 |
Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium.
Commitment of the pulmonary epithelium to bronchial and bronchiolar airway lineages occurs during the transition from pseudoglandular to cannalicular phases of lung development, suggesting that regional differences exist with respect to the identity of stem and progenitor cells that contribute to epithelial maintenance in adulthood. We previously defined a critical role for Clara cell secretory protein-expressing (CE) cells in renewal of bronchiolar airway epithelium following injury. Even though CE cells are also the principal progenitor for maintenance of the bronchial airway epithelium, CE cell injury is resolved through a mechanism involving recruitment of a second progenitor cell population that we now identify as a GSI-B(4) reactive, cytokeratin-14-expressing basal cell. These cells exhibit multipotent differentiation capacity as assessed by analysis of cellular phenotype within clones of LacZ-tagged cells. Clones were derived from K14-expressing cells tagged in a cell-type-specific fashion by ligand-regulable Cre recombinase-mediated genomic rearrangement of the ROSA26 recombination substrate allele. We conclude that basal cells represent an alternative multipotent progenitor cell population of bronchial airways and that progenitor cell selection is dictated by the type of airway injury. Topics: Animals; Antiviral Agents; Bronchi; Cell Lineage; Epithelium; Estrogen Antagonists; Female; Ganciclovir; Immunohistochemistry; Keratins; Mice; Mice, Transgenic; Naphthalenes; Regeneration; Stem Cells; Tamoxifen | 2004 |